netFormulary
 Report : A-Z of formulary items 24/10/2020 16:36:01
[Back]
 
Section Name Details
10.01.03 Abatacept 

Orencia®

02.08.02 Acenocoumarol Sinthrome®
11.06 Acetazolamide 

Diamox®

Injection Red 

11.08.02 Acetylcholine Chloride 

intra ocular irrigation 1% preservative free

Miochol E®

03.07 Acetylcysteine 
11.03.03 Aciclovir eye ointment 3% 

Herpes simplex corneal infections - Hospital supervision

Zovirax®

13.05.02 Acitretin 
03.01.02 Aclidinium 

Asthma:                             COPD:

Not licensed

Black                            Green

Eklira Genuair ®

03.01.04 Aclidinium and formoterol inhaler 

Asthma:                                                 COPD:

Black                                               Green

Not Licensed

Duaklir Genuair ®

01.05.03 Adalimumab 

Injection 40 mg prefilled pen or prefilled syringe, 40 mg/0.8 ml vial

Should only be used under expert supervision

10.01.03 Adalimumab 

Humira®

13.05.03 Adalimumab 
13.06.01 Adapalene 

Differin ®

cream / gel

02.03.02 Adenosine Adenocor®
03.04.03 Adrenaline / epinephrine 

EpiPen®; Jext®

03.04.03 Adrenaline / epinephrine 1 in 1,000 
02.07.03 Adrenaline / Epinephrine 1 in 10,000 (dilute) 
11.08.02 Aflibercept 40mg/1ml 

Eyelea®

06.06.02 Alendronic Acid 
06.06.02 Alendronic Acid 
09.06.04 Alfacalcidol 

One -Alpha®

07.04.01 Alfuzosin 
03.04.01 Alimemazine Vallergan®
02.12 Alirocumab Praluent®
13.05.01 Alitretinoin Toctino®
10.01.04 Allopurinol 
06.01.02.03 Alogliptin 
09.06.05 Alpha Tocopheryl Acetate 
13.09 Alphosyl 2 in 1® 

Coal Tar Extract 5% (Alcoholic)

 for chronic conditions

07.01.01.01 Alprostadil Prostin VR®

500microgram/ml injection

Maintenance of patency

07.04.05 Alprostadil 

 Caverject®; MUSE®; Viridal®  

02.10.02 Alteplase Actilyse®
02.10.02 Alteplase 2mg Actilyse Cathflo®
09.05.02.02 Aluminium Hydroxide 

Alu-Cap®

01.02 Alverine citrate 

Capsules 60 mg

04.09.01 Amantadine 
02.02.03 Amiloride Hydrochloride 
03.01.03 Aminophylline 
03.01.03 Aminophylline IV 
02.03.02 Amiodarone 
04.02.01 Amisulpride 

LCFT INITIATION ONLY

04.03.01 Amitriptyline 
04.07.03 Amitriptyline 
02.06.02 Amlodipine 
11.08.02 Amphotericin (intravitreal) 
11.03.02 Amphotericin 0.15% eye drops 

Ophthalmology Use Only

09.01.04 Anagrelide 
08.03.04.01 Anastrozole 
01.01.01 Antacid and Oxetacaine SF suspension 

Unlicensed Oncology use only

01.07.01 Anusol® 

Cream 23 g, Ointment 25 g, suppositories 12

01.07.02 Anusol-HC 

Ointment 30 g, cream 30 g, suppositories 12

02.08.02 Apixaban Eliquis®

 Prevent of stroke and systemic embolism in people with nonvalvular atrial fibrillation

04.09.01 Apomorphine 
11.08.02 Apraclonidine 0.5% eye drops 

Iopidine®

13.05.03 Apremilast 

Otezla®

04.06 Aprepitant 

Emend®

13.02.01 Aqueous Cream BP 

For use as a soap substitute

Not recommended for use as an emollient

01.06.03 Arachis Oil 

Enema 130 ml

02.08.01 Argatroban Exembol®
04.02.01 Aripiprazole 

LCFT INITIATION ONLY

04.02.02 Aripiprazole 

LCFT ONLY

Abilify Maintena®

12.03.05 Artificial saliva spray Salivese®
07.04.03 Ascorbic Acid Vitamin C
09.06.03 Ascorbic Acid Vitamin C

50mg, 100mg and 500mg tablets

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

02.09 Aspirin (antiplatelet) 
10.02 Ataluren 

Translarna®

Treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD)

02.04 Atenolol 
04.04 Atomoxetine 

Strattera®

02.12 Atorvastatin 
07.01.03 Atosiban 

injection

concentrate for IV infusion

11.05 Atropine 0.01% eye drops 

unlicensed

eye drops;

To be prescribed under the supervision of a Consultant Ophthalmologist only

To slow the progress of myopia in children

11.05 Atropine 1% eye drops 

eye drops; unit dose eye drops

13.02.01 Aveeno® 

Emollient containing colloidal oatmeal

Medium emollient

Cream

For ACBS approved indication only: Endogenous and exogenous eczema, xeroderma, ichthyosis and senile pruritis and assocaited with dry skin

01.05.03 Azathioprine 

Tablets 25 mg, 50 mg

Should only be used under expert supervision

Unlicensed use - IBD

08.02.01 Azathioprine 
10.01.03 Azathioprine 
13.05.03 Azathioprine 
13.06.01 Azelaic Acid 

Skinoren ® cream 20%

12.02.01 Azelastine Hydrochloride Rhinolast®
11.03.01 Azithromycin 

Chlamydia  conjuctivitis

Oral

07.04.04 Bacillus calmette-guerin  ImmuCyst® or OncoTice®

consultant/hospital only

10.02.02 Baclofen 
13.02.01 Balneum® Plus  

Cream

Urea 5%

01.05.01 Balsalazide 

Consultant Initiation

Capsules 750 mg

03.02 Beclometasone 

Asthma:                                            COPD:

                                        Black


Beclometasone Diproprionate CFC-free MDIs must be prescribed by brand name; different brands are not interchangable 

Refer to the latest version of the BNF for the most cost-effective brand of Beclometasone Diproprionate inhaler

03.02 Beclometasone and formoterol 

Asthma:                                        COPD:

Fostair® ; Fostair® NEXThaler

MHRA Advice 2008: Fostair® contains extra-fine particles of beclometasone dipropionate and is more potent than traditional beclometasone dipropronate CFC-free inhalers. The dose of beclometaone dipropionate in Fostair® should be lower thana non-extra-fine formulations of beclometasone dipropionate and will need to be adjusted to the needs of the individual patient.

12.02.01 Beclometasone Dipropionate nasal spray Beconase®

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

03.02 Beclometasone with Formoterol and Glycopyrronium Trimbow

Asthma:                                                                 COPD:   

 Not licensed for asthma                                             


Maintenance treatment in adult patients with moderate to severe COPD who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta 2-agonist.

Triple therapy should be reserved for patients who have failed to achieve or maintain an adequate response to an appropriate course of dual therapy.

03.04.02 Bee and Wasp Allergen Extracts Pharmalgen®
02.02.01 Bendroflumethiazide 
03.04.02 Benralizumab Fasenra®

Treatment of severe refractory eosinophilic asthma

 

13.06.01 Benzoyl Peroxide 
13.06.01 Benzoyl Peroxide 5% with Clindamycin 1% Duac® Once Daily

Duac ® Once Daily

12.03.01 Benzydamine Difflam®

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

04.06 Betahistine Dihydrochloride 
06.03.02 Betamethasone Betnesol®
13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 2% 

Diprosalic ® scalp application 100ml

Potency: potent

13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% 

Diprosalic ®  30g ointment

Potency: Potent with salicyclic acid

13.04 Betamethasone (as Valerate) 0.025% 

Betnovate-RD® cream / ointment 100g

 

Potency: Moderate

13.04 Betamethasone (as Valerate) 0.1% 

Betnovate® cream / ointment 30g / 100g

 

Potency: Potent

13.04 Betamethasone (as Valerate) 0.1% with Clioquinol 

30g cream / ointment

Potency: Potent with antimicrobial

13.04 Betamethasone (as Valerate) 0.1% with Fucidic Acid 2% 

Fucibet ® cream 39g

Potency: Potent with antibacterial

11.04.01 Betamethasone 0.1% with Neomycin 0.5% eye drops 

Betnesol N®

12.03.01 Betamethasone 500mcg tablets 

Dissolve in 20ml water and rinse around the mouth 4 times daily; not to be swallowed.

13.04 Betamethasone Dipropionate 0.064% with Clotrimazole 1% 

Lotriderm 30g cream

Potency: Potent with antifungal

12.01.01 Betamethasone ear drops 
13.04 Betamethasone Esters 

Betacap ® 100ml scalp application

Potency: potent

11.04.01 Betamethasone eye drops 
12.02.01 Betamethasone nasal drops 
11.08.02 Bevacizumab intravitreal injection 

Avastin®

02.12 Bezafibrate 
08.03.04.02 Bicalutamide 
11.06 Bimatoprost 

100micrograms / ml eye drops

300 micrograms / ml eye drops; unit dose eye drops (amber)

11.06 Bimatoprost with Timolol 

Ganfort®

12.03.05 Biotene Oralbalance® 
06.01.01.02 Biphasic Insulin Aspart 

NovoMix® 30 Flexpen; 3ml Penfill

06.01.01.02 Biphasic Insulin Lispro 

Humalog® Mix 25 10ml vial; Kwikpen; 3ml cartrdige

Humalog® Mix 50 Kwikpen; 3ml cartridge

06.01.01.02 Biphasic Isophane Insulin 

Humulin® M3 Kwikpen; 3ml cartridge

01.06.02 Bisacodyl 

Tablets e/c 5 mg

Suppositories 10 mg

Paediatric suppositories 5 mg

02.04 Bisoprolol 
04.07.04 Botulinum Toxin Type A 
04.09.03 Botulinum Toxin Type A 

Xeomin®; Dysport®; Botox®

04.09.03 Botulinum Toxin Type A 

Xeomin®; Dysport®; Botox®

13.12 Botulinum toxin type A  
11.06 Brimonidine 0.2% Tartrate 

Alphagan®

11.06 Brinzolamide 

Azopt®

10mg/ml eye drops

11.06 Brinzolamide 1% with Timolol 0.5%  

Azarga®

11.06 Brinzolamide 10mg/ml & brimonidine 2mg/ml 

Simbrinza®

04.08.01 Brivaracetam Briviact®
13.05.03 Brodalumab 

Kyntheum ®

06.07.01 Bromocriptine 
01.05.02 Budesonide Cortiment MMX®

Tablets 9 mg m/r

01.05.02 Budesonide Entocort®

CR Capsules, enclosing e/c, m/r granules 3 mg

01.05.02 Budesonide  Budenofalk®

3mg gastro-resistant Capsule

2mg per actuation foam enema

03.02 Budesonide 

Asthma:                                                   COPD:

Green Traffic Light                                           Black

 

03.02 Budesonide and formoterol 

DuoResp Spiromax® ; Symbicort Turbohaler ®

02.02.02 Bumetanide 
04.10.03 Buprenorphine Subutex®
03.04.03 C1 Esterase Inhibitor 

Berinert®; Cinryze® Restricted Item 

04.09.01 Cabergoline 
06.07.01 Cabergoline 
03.05 Caffeine Citrate 

10mg/ml Caffeine Citrate Oral Solution

20mg/ml Caffeine Citrate for IV Infusion

13.05.02 Calcipotriol 

50 micrograms per ml Ointment 30g / 60g / 100g

Dovonex ®

50 micrograms per ml Scalp solution 60ml / 120ml

13.05.02 Calcipotriol 50micrograms/g with Betamethasone 0.05% 

Dovobet ® ointment 30g / 60g / 120g

Dovobet ® gel 60g

Enstilar ® Foam 60g / 120g

13.05.02 Calcitriol 3micrograms/g 

Silkis ® ointment 100g

09.05.02.02 Calcium Acetate 

Phosex®

09.05.02.02 Calcium Carbonate 

Calcichew®

09.05.01.01 Calcium Chloride 

Injection

09.05.01.01 Calcium Gluconate 

Injection

09.05.01.01 Calcium Salts 

Calcium carbonate - Calcichew®; Adcal®

Calcium carobonate with calcium lactate gluconate - Sandocal®

09.05.02.02 Calcium Salts 

Osvaren®

06.01.02.03 Canagliflozin 
02.05.05.02 Candesartan 
04.06 Cannabidiol 2.5mg/dose Sativex oromucosal spray®
13.09 Capasal® 

Salicyclic Acid 5mg per 1g, Coal Tar 10mg per 1g, Coconut Oil 10mg per 1g.

 for chronic conditions

04.07.03 Capsaicin 

0.025% - Unlicensed in Neuropathic Pain

0.075% - Licensed for post-herpetic neuralgia after open skin lesions have healed and painful diabetic peripheral polyneuropathy

 

04.07.03 Carbamazepine 
04.08.01 Carbamazepine 
06.02.02 Carbimazole 

Neo-Mercazole®

03.07 Carbocisteine 
11.08.01 Carbomers 0.2% 

Viscotears® GelTears®

07.01.01 Carboprost Hemabate®

injection

11.08.01 Carmellose unit dose eye drops 

0.5% & 1% Celluvisc®

02.04 Carvedilol 
11.03.01 Cefuroxime eye drops 

Unlicensed preparation 5% eye drops

11.08.02 Cefuroxime injection 
10.01.03 Certolizumab Pegol 

Cimzia®

03.04.01 Cetirizine 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

13.02.01 Cetraben® 

Light emollient

Cream

Ointment

11.03.01 Chloramphenicol  

bacterial conjuctivitis

0.5% eye drops

1% eye ointment

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

11.03.01 Chloramphenicol 1% eye ointment 

Corneal abrasions

04.10 Chlordiazepoxide 
11.09 Chlorhexidine 0.02% eye drops 
12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin®
12.03.04 Chlorhexidine mouthwash 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

13.05.03 Chloroquine 
03.04.01 Chlorphenamine 

Drug included within CCG low priority prescibing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

 

Red Injection

04.02.01 Chlorpromazine 
11.03.01 Chlortetracycline 1% 

chlamydia conjunctivitis

eye ointment - unlicensed preparation - Ophthalmology use only

12.03.01 Choline Salicylate Bonjela® Adult

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

07.04.04 Chondroitin sulfate 0.2% bladder instillation Gepan®
03.02 Ciclesonide 

Alvesco®

01.05.03 Ciclosporin 

Capsules 25 mg, 50 mg, 100 mg

100 mg/1 ml oral solution

Concentrate for intravenous infusion (oily) 50 mg/1 ml

Should only be used under expert supervision

08.02.02 Ciclosporin 
10.01.03 Ciclosporin 
11.99.99.99 Ciclosporin 

Ikervis®

13.05.03 Ciclosporin 
13.03 Cimetidine 

Unlicensed indication

Dermatology initiation only

09.05.01.02 Cinacalcet Mimpara®
01.07.02 Cinchocaine with hydrocortisone 

Radiotherapy patients only

Ointment

Suppositories

Uniroid HC

Proctosedyl

04.06 Cinnarizine 
12.01.01 Ciprofloxacin 0.3% 

(unlicensed use of eye drops)

04.03.03 Citalopram 
07.04.04 Citric acid 3.23%, magnesium oxide 0.38%, sodium bicarbonate 0.7%, disodium edetate 0.01% 
08.01.03 Cladribine 

Treatment of highly active relapsing-remitting multiple sclerosis in adults

13.06.02 Clarithromycin 
13.06.01 Clindamycin 1% Dalacin T®

Dalacin T ®

07.02.02 Clindamycin 2% vaginal cream 
04.08.01 Clobazam 
13.04 Clobetasol Propionate 0.05% 

Clobaderm® cream / ointment 30g / 100g

Dermovate® cream / ointment 30g / 100g

 

Potency: Very potent

13.04 Clobetasone Butyrate 0.05% 

Eumovate® Cream / Ointment 30g / 100g

 

Potency: Moderate

13.04 Clobetasone butyrate 0.05% with Oxytetracycline 3% and Nystatin 10,000 units per gram 

Trimovate ® cream 

Potency: Moderate with antibacterial and antifungal

06.05.01 Clomifene Citrate 
04.03.01 Clomipramine 
04.08.01 Clonazepam 

GREEN unlicensed anxiety

02.05.02 Clonidine Catapres®

oral Amber

injection RED

02.09 Clopidogrel 
07.02.02 Clotrimazole 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

13.10.02 Clotrimazole 
04.02.01 Clozapine 

LCFT ONLY

13.05.02 Coal tar in Yellow Soft Paraffin  Special order - various strengths
13.05.02 Coal tar lotion 5% 

Exorex ® Lotion 100ml / 250ml

13.05.02 Coal tar with salicyclic acid and precipitated sulfur 

Cocois ® ointment 40g / 100g

02.02.04 Co-amilofruse (furosemide and amiloride) 
04.09.01 Co-Beneldopa Madopar®
04.09.01 Co-Beneldopa Madopar®CR
04.09.01 Co-Careldopa Sinemet®
04.09.01 Co-Careldopa and Entacapone Stalevo ®
04.07.01 Co-Codamol 30/500 

NOT for INPATIENT USE - use seperate components

Hospital - Emergency Department only

13.06.02 Co-Cyprindiol 2000/35
(Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
 

Dianette®

01.06.02 Co-danthrusate Dantron

Capsules 50/60 (dantron 50 mg, docusate sodium 60 mg)

Suspension 50/60 (dantron 50 mg, docusaate sodium 60 mg/5 ml)

Palliative Care Only

01.04.02 Codeine 

Tablets 15 mg, 30 mg

Syrup 25 mg/5 ml

04.07.02 Codeine 
10.01.04 Colchicine 
13.05.03 Colchicine 

Unlicensed Indication

09.06.04 Colecalciferol 

Plenachol® 20,000 unit and 40,000 unit capsules

09.06.04 Colecalciferol 

400 unit capsule & 800 unit capsule 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

09.06.04 Colecalciferol and Calcium Carbonate 

Adcal D3; Calcichew D3 forte; Accrete D3

02.12 Colestyramine 
01.09.02 Colestyramine powder 

Powder 4 g/sachet

Consultant initiation

Unlicensed use - Diarrhoea secondary to bile acid malabsorption

01.01.01 Co-magaldrox Mucogel®

Suspension, sugar-free, co-magaldrox 195mg/220mg5ml (magnesium hydroxide 195mg, dried aluminium hydroxide 220mg per 5ml)

Low Sodium

Equivalent to Maalox but less expensive

 

06.04.01.01 Combined continuous HRT patch 

Evorel® Conti

06.04.01.01 Combined continuous HRT tablet 

Kliofem® Kliovance® Femoston Conti® Premique® Elleste-Duet Conti®

06.04.01.01 Combined cyclical HRT patch 

Evorel Sequi®

06.04.01.01 Combined cyclical HRT tablet 

Elleste-Duet® Femoston® Prempak-C®

13.02.02 Conotrane® 
01.04.02 Co-Phenotrope Lomotil®

Consultant Initiation

Tablets Atropine sulfate 25 microgram, Diphenoxylate hydrochloride 2.5 mg

04.06 Cyclizine 
04.06 Cyclizine 
13.10.04 Cyclomethicone 50% / Isopropyl myristate 50% solution 

Full Marks Solution ®

Headlice Treatment

11.05 Cyclopentolate eye drops 

0.5% eye drops; unit dose eye droops

1% eye drops; unit dose eye drops

 

08.03.04.02 Cyproterone 
06.04.02 Cyproterone Acetate 
02.08.02 Dabigatran Pradaxa®
02.08.01 Dalteparin 
02.08.01 Danaparoid Orgaran®
06.07.02 Danazol 
10.02.02 Dantrolene 
06.01.02.03 Dapagliflozin 

Treating type 2 diabetes:  Green

Combination therapy for treating type 2 diabetes : Green (restricted)

Triple therapy for treating type 2 diabetes: Green

 

Use with insulin for treating type 1 diabetes:   Amber

13.05.03 Dapsone 
09.01.03 Darbepoetin Alfa 

Aranesp®

10.03.02 Deap Heat Rub 

For capillary blood gas testing only

09.01.03 Deferiprone Ferriprox®
06.05.02 Demeclocycline 
06.06.02 Denosumab XGEVA®

prevention of osteoporotic fractures in men and post menopausal women: 

Amber 1

treatment of Glucocorticoid-induced osteoporosis: Amber 1

 

Bone metastasis from solid tumours: Red

 

07.02.02 Dequalinium choride 10mg vaginal tablets 
13.09 Dermax® 

Benzalkonium chloride 5mg per 1ml

 for chronic conditions

13.02.01 Dermol 500®  Lotion

Preparations containing an antibacterial should be avoided unless infection is present or is a frequent complication

13.02.01 Dermol® 

Cream

Preparations containing an antibacterial should be avoided unless infection is present or is a frequent complication

09.01.03 Desferrioxamine Mesilate 
03.04.01 Desloratadine Neoclarityn®
06.05.02 Desmopressin 
07.04.02 Desmopressin 
07.03.02.01 Desogestrel Cerazette®, Cerelle®
06.03.02 Dexamethasone 
08.02.02 Dexamethasone 
11.04.01 Dexamethasone 0.1% eye drops 

Maxidex®

eye drops

single dose eye drops preservative free

11.04.01 Dexamethasone intravitreal implant Ozurdex®
12.01.01 Dexamethasone with Antibacterial Otomize®
12.01.01 Dexamethasone with Antibacterials (ear) Sofradex®
04.04 Dexamfetamine 
04.07.02 Diamorphine 
04.01.02 Diazepam 
04.08.02 Diazepam epilepsy
10.02.02 Diazepam 
10.01.01 Diclofenac 
10.01.01 Diclofenac  Green restricted - ensure cardiovascular risk assessment is conducted prior to prescribing. Not to be initiated in secondary care.
13.08.01 Diclofenac 

Solaraze ® 3% gel

08.03.01 Diethylstilbestrol 
13.04 Diflucortolone Valerate 

Nerisone® 0.1% ointment / cream / oily cream 30g

Potency: Potent

Nerisone® Forte 0.3% ointment / oily cream 15g

Potency: Very Potent

02.01.01 Digoxin 
02.01.01 Digoxin-specific antibody fragments 40mg DigiFab
04.07.02 Dihydrocodeine 
02.06.02 Diltiazem 
01.07.04 Diltiazem Cream 2% 

Cream 30 g

Second choice

08.02.04 Dimethyl fumarate 

Tecfidera®

Treatment of relapsing-remitting multiple sclerosis

13.05.03 Dimethyl Fumarate 

Skilarence 30mg and 120mg

13.10.04 Dimeticone 

Hedrin ®

Headlice Treatment

07.01.01 Dinoprostone 

Propess® pessaries; Prostin E2® Vaginal gel, Vaginal tablets

13.02.01 Diprobase® 

Medium Emollient

Cream

Ointment

02.09 Dipyridamole 200mg MR Persantin® Retard
02.03.02 Disopyramide 
13.05.02 Dithranol 

Dithrocream ® 0.1%, 0.25%, 0.5%, 1% & 2% 50g

02.07.01 Dobutamine 
01.06.02 Docusate 

Capsules 100 mg

Adult oral solution, sugar-free, 50 mg/5 ml

Paediatric oral solution, sugar-free, 12.5 mg/5 ml

04.06 Domperidone 
04.11 Donepezil 

Tablet, Orodispersible Tablet, Oral Solution

02.07.01 Dopamine 
03.07 Dornase Alfa Pulmozyme®

Shared Care between Specialist Centre and Secondary Care

11.06 Dorzolamide 2% 

Trusopt®

2% eye drops

2% single use eye drops preservative free

11.06 Dorzolamide 2% with Timolol 0.5% 

Cosopt ®

Eye Drops, unit dose 

13.02.01 DoubleBase® 

Medium Emollient

Gel

03.05.01 Doxapram Dopram®
02.05.04 Doxazosin 
04.03.01 Doxepin 
13.03 Doxepin Xepin®

5% cream

Only licensed for pruritis in eczema

Not recommended in under 12 years

02.03.02 Dronedarone Multaq®
02.11 Drotrecogin Alfa (Activated) Xigris®
06.01.02.03 Dulaglutide  

Trulicity®

Once Weekly Dose

04.03.04 Duloxetine 
04.07.03 Duloxetine 
07.04.02 Duloxetine Yentreve®
13.05.03 Dupilumab 
06.04.02 Dutasteride Avodart®
13.02.01 E45® 

Light emollient

Cream

13.10.02 Econazole Pevaryl®
02.08.02 Edoxaban Lixiana®
10.02.01 Edrophonium Chloride 
01.05 Eluxadoline 

Consultant Gastroenterologist initiation only

06.01.02.03 Empagliflozin 
13.02.01 Emulsifying Ointment BP 

Heavy Emollient

Ointment

02.08.01 Enoxaparin 
04.09.01 Entacapone Comtess®
13.02.01 Epaderm® 

Heavy Emollient

Cream

Ointment

02.07.02 Ephedrine 
12.02.02 Ephedrine nasal drops 

Drug included in CCG low priority prescribing policy. DO NOT PRESCRIBE IN PRIMARY CARE.

02.02.03 Eplerenone 
09.01.03 Epoetin beta 

NeoRecormon®

02.08.01 Epoprostenol Flolan®
03.07 Erdosteine 

Erdotin®

09.06.04 Ergocalciferol 
07.01.01 Ergometrine Maleate 

IM injection

07.01.01 Ergometrine Maleate and Oxytocin Syntometrine®

IM injection

06.01.02.03 Ertugliflozin Steglatro®

Green (restricted)

13.06.01 Erythromycin 40mg with Zinc Acetate 12mg/mL Zineryt®

Zineryt ®

04.03.03 Escitalopram 

Major depressive illness only

04.08.01 Eslicarbazepine Zebinix®
02.04 Esmolol 
01.03.05 Esomeprazole 

Consultant Initiation

Capsules / tablets 20 mg, 40 mg

Granules 10 mg/sachet N.B. Granules are much more expensive.

Injection, powder for solution for Injection/Infusion 40 mg

10.01.03 Etanercept 

Enbrel®

13.05.03 Etanercept 
06.06.01 Etelcalcetide Parsabiv®
06.04.01.01 Ethinylestradiol 
07.03.01 Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel®, Mercilon®. Munalea®
07.03.01 Ethinylestradiol 30 mcg / drospirenone 3 mg Yasmin®
07.03.01 Ethinylestradiol 30 mcg / levonorgestrel 150 mcg Ovranette®
07.03.01 Ethinylestradiol 30mcg / desogestrel 150mcg Gedarel®, Marvelon®
07.03.01 Ethinylestradiol 30mcg / gestodene 75 mcg Millinette®, Femodene®,
07.03.01 Ethinylestradiol 30mcg / levonorgestrel 150mcg Rigevidon®, Microgynon 30®, Levest®
07.03.01 Ethinylestradiol 30mcg/norethisterone 1.5mg Loestrin 30®
07.03.01 Ethinylestradiol 33.9mcg/24hrs, norelgestromin 203mcg/24hrs Evra
07.03.01 Ethinylestradiol 35 mcg / noresthisterone 1mg Norimin®
07.03.01 Ethinylestradiol 35 mcg / noresthisterone 500mcg Ovysmen®, Brevinor®
07.03.01 Ethinylestradiol 35mcg/ norgestimate 250mcg Cilest®
04.08.01 Ethosuximide 
07.03.02.02 Etonorgestrel Nexplanon ®
10.01.01 Etoricoxib 

Arcoxia®

02.12 Evolocumab Repatha®
08.03.04.01 Exemestane 
02.12 Ezetimibe Ezetrol®
08.02.04 Fampridine 
10.01.04 Febuxostat 

Adenuric®

02.12 Fenofibrate 
04.07.02 Fentanyl 
09.01.01.02 Ferric Carboxymaltose 

Ferinject®

09.01.01.01 Ferrous Fumarate 
09.01.01.01 Ferrous Sulphate 
03.04.01 Fexofenadine 
09.01.06 Filgrastim 

Zarzio®

06.04.02 Finasteride 
07.04.01 Finasteride 
08.02.04 Fingolimod 

• Treatment of highly active relapsing remitting multiple sclerosis after 1st line treatment as per NICE TA245

• Treatment of highly active relapsing remitting multiple sclerosis after Natalizumab treatment

02.03.02 Flecainide 
13.04 Flucinolone Acetonide 0.0025% 

Synalar 1 in 10 Dilution® cream 50g

Potency : Mild

13.04 Flucinolone Acetonide 0.00625% 

Synalar 1 in 4 Dilution® cream / ointment 50g

Potency : Moderate

13.04 Flucinolone Acetonide 0.025% Synalar®

Synalar® cream / gel / ointment 30g

Potency : potent

13.04 Flucinonide 0.05% Metosyn®

Metosyn® ointment / cream 25g / 100g

Potency : Potent

06.03.01 Fludrocortisone 
13.04 Fludroxycortide  

0.0125% cream / ointment 60g

4 microgram per 1 square cm tape 7.5cm x 20cm

Potency : moderate

12.01.01 Flumetasone 0.02% with Clioquinol 1% Locorten-Vioform®
13.04 fluocinolone acetonide 0.025% with clioquinol 3% Synalar C®

Synalar C ® 15g cream / ointment

Potency: Potent with antimicrobial

11.08.02 Fluorescein Sodium 
11.04.01 Fluorometholone 0.1% 

FML®

11.99.99.99 Fluorouracil 
13.08.01 Fluorouracil 

Efudix ®

04.03.03 Fluoxetine 
04.02.02 Flupentixol Decanoate 

LCFT INITIATION ONLY

Depixol®

04.02.01 Fluphenazine Hydrochloride 
03.02 Fluticasone furoate & vilanterol Relvar Ellipta®

• COPD                              • Asthma in adults aged 17 and over


                                    

03.02 Fluticasone furoate with Umeclidinium and Vilanterol  Trelegy Ellipta ®

Restricted Item 

Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist.

Triple therapy should be reserved for patients who have failed to achieve or maintain an adequate response to an appropriate course of dual therapy.

03.02 Fluticasone propionate 

Flixotide® accuhaler and evohaler

NB nebuliser liquid is non-formulary

12.02.01 Fluticasone Propionate Flixonase Nasule®

for nasal polyps

13.04 Fluticasone Propionate 

Cutivate®  cream (0.05%)  / ointment (0.005%) 15g / 30g

Potency : Potent

03.02 Fluticasone propionate and formoterol 

Flutiform®

Flutiform K®

03.02 Fluticasone propionate and salmeterol 

Sirdupla® ; Seretide®

12.02.01 Fluticasone Propionate nasal spray 
09.01.02 Folic Acid 

400microgram and 5mg tablets

2.5mg/5ml SF syrup

02.08.01 Fondaparinux Arixtra®
03.01.01.01 Formoterol  

Asthma:                                     COPD:

Oxis Turbohaler®; Easyhaler; 

04.06 Fosaprepitant 

Ivemend®

08.03.04.01 Fulvestrant Faslodex®
02.02.02 Furosemide 
13.10.01.02 Fusidic Acid 

2% cream Fucidin ® 15g, 30g

11.03.01 Fusidic Acid 1% Modified Release eye drops 

Blepharitis

eye drops

04.07.03 Gabapentin 
04.08.01 Gabapentin 
04.09.04 Gabapentin 
04.11 Galantamine 

Tablet, Modified Release Capsule, Oral Solution

12.03.05 Gelclair sachets 

Palliative care advice only

11.03.01 Gentamicin 0.3% eye drops 

bacterial conjuctivitis

Genticin®

 

11.03.01 Gentamicin 1.5% eye drops preservative free 

Ophthalmology use only

08.02.04 Glatiramer Acetate Copaxone®

Treatment of relapsing-remitting multiple sclerosis in adults

06.01.02.01 Gliclazide 
06.01.02.01 Glimepiride 
01.02 Glucagon Glucagen®

Examinations of gi tract by radiography or endoscopy

06.01.04 Glucagon 

GlucaGen® HypoKit

06.01.04 GlucoGel® 
12.02.02 Glucose 25% in glycerin nose drops 

special from preston pharmaceuticals

12.03.05 Glycerin and lemon swabs 

For hospital inpatients only

01.06.02 Glycerol 

Suppositories 1 g, 2 g, 4 g

02.06.01 Glyceryl Trinitrate 

spray and patches

01.07.04 Glyceryl Trinitrate 0.4% 

Ointment 30 g

02.06.01 Glyceryl Trinitrate 50mg/50ml  
07.04.04 Glycine 
03.01.02 Glycopyrronium 

Asthma:                                     COPD:

Not licensed

Black                                   Green

Seebri breezhaler®

13.12 Glycopyrronium 
01.05.03 Golimumab 

Injection, Prefilled syringe 90 mg

Should only be used under expert supervision

10.01.03 Golimumab 

Simponi®

06.05.01 Gonadorelin 

GnRH

06.07.02 Goserelin 
08.03.04.02 Goserelin Zoladex®
04.06 Granisetron 
04.04 Guanfacine 

Intuniv®

13.05.03 Guselkumab 

Tremfya ®

04.02.01 Haloperidol 
04.06 Haloperidol 
04.02.01 Haloperidol decanoate injection 
04.02.01 Haloperidol injection 
02.08.01 Heparin 
02.08.01 Heparin 
07.04.04 Hyaluronic acid  Cystistat®

Consultant/hospital only

Use in interstitial cystitis - Unlicensed use

10.03.01 Hyaluronidase Hyalase®
02.05.01 Hydralazine 

injection RED

01.05.02 Hydrocortisone Colifoam ®

Rectal foam in aerosol pack, hydrocortisone acetate 10%

06.03.02 Hydrocortisone 
12.03.01 Hydrocortisone Corlan®
13.04 Hydrocortisone 

0.5%, 1%, 2.5% cream / ointment 15g / 30g

 

Potency: Mild

10.01.02.02 Hydrocortisone acetate 

Hydrocortistab®

13.04 Hydrocortisone 1% with Clotrimazole 1% 

Canesten HC® 30g cream

Potency: Mild with antifungal

13.04 Hydrocortisone 1% with Miconazole Nitrate 2% 

Daktacort® 30g cream / ointment

Potency: mild with antifingal

13.04 Hydrocortisone Acetate 1% with Fusidic Acid 2% 

Fucidin H® cream 30g

Potency: mild with antibacterial

12.01.01 Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone® HC
13.04 Hydrocortisone Butyrate 

Locoid® 0.1% cream / lipocream / ointment 30g / 100g

Potency: Potent

13.11.06 Hydrogen Peroxide Solution BP 
13.02.01 Hydromol®  

Heavy Emollient

Cream

Ointment

09.01.02 Hydroxocobalamin 
13.05.03 Hydroxycarbamide 

Unlicensed Indication

10.01.03 Hydroxychloroquine 
13.05.03 Hydroxychloroquine 
11.08.01 Hydroxypropyl Guar 

Systane®

03.04.01 Hydroxyzine 
01.02 Hyoscine Butylbromide Buscopan

Tablets 10mg

Injection 20 mg per 1 ml

04.06 Hyoscine Hydrobromide 
11.08.01 Hypromellose 0.3% eye drops 

Included in the CCG Low Priority for Prescribing Policy.

06.06.02 Ibandronic Acid 
06.06.02 Ibandronic Acid injection Bondronat
07.01.01.01 Ibuprofen Pedea® injection

Closure of the ductus arteriosus

10.01.01 Ibuprofen 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug

10.03.02 Ibuprofen gel 

5%

03.04.03 Icatibant 

Firazyr®

13.05.01 Ichthammol 
02.08 Idarucizumab Praxbind®
02.05.01 Iloprost injection  
04.03.01 Imipramine 
13.07 Imiquimod Aldara®

Aldara ® 

02.02.01 Indapamide 
13.10.05 Indermil® 
10.01.01 Indometacin 
01.01.02 Infant Gaviscon® 

Oral powder, sugar-free, Magnesium alginate 87.5 mg, Sodium alginate 225 mg. Contains 0.92 mmol Na+/dose 

01.05.03 Infliximab 

Intravenous infusion, powder for reconstitution, 100 mg

Should only be used under expert supervision

10.01.03 Infliximab 

Remicade®; Remsima

13.05.03 Infliximab 
06.01.01.01 Insulin - Soluble Human 

Actrapid® 10ml vial; 

Humulin S® 10ml vial; 3ml cartridges

06.01.01.01 Insulin 500 units in 1mL 

Humulin R Kwikpen®

06.01.01.01 Insulin Aspart  

Fiasp® 10ml vial; FlexTouch pen; 3ml cartridge

06.01.01.01 Insulin Aspart  

NovoRapid® 10ml vial; FlexPen; 3ml penfill; PumpCart; FlexTouch

06.01.01.02 Insulin degludec Tresiba®

Tresiba® pre-filled pen

Green (restricted) 

06.01.01.02 Insulin Detemir 

Levemir® Flexpen; InnoLet; 3ml Penfill

06.01.01.02 Insulin Glargine 

Abasaglar® Kwikpen; 3ml cartridges

Lantus® 10ml vial; 3ml cartridges; Solostar pen

06.01.01.02 Insulin Glargine 

Toujeo® 300units per ml Solostar pen

             

06.01.01.01 Insulin Glulisine 

Apidra® 10ml vial; Solostar pen

06.01.01.01 Insulin Lispro 100 units/ml 

Humalog® 10ml vial; Kwikpen; 3ml cartridges

08.02.04 Interferon Alfa 
08.02.04 Interferon Beta Avonex®
07.03.04 Intra-uterine Contraceptive Devices Load® 375
07.03.04 Intra-uterine Contraceptive Devices T-Safe® CU 380 A
07.03.02.03 Intra-uterine Progestogen Only System Jaydess®
07.03.02.03 Intra-uterine Progestogen Only System Mirena®
06.02.02 Iodine and Iodide 
03.01.02 Ipratropium 

Asthma:                              COPD:

Green                             Green

MDI; nebuliser

Caution: Acute angle-closure glaucoma has been reported with nebulised ipratropium, particularly when given with nebulsed salbutamol (and possibly other beta2agonists): care needed to protect patient's eyes from nebulised drug or from drug powder.

12.02.02 Ipratropium Bromide Rinatec®
02.05.05.02 Irbesartan 
09.01.01.02 Iron Dextran 

CosmoFer®

09.01.01.02 Iron Sucrose 

Venofer®

06.01.01.02 Isophane Insulin 

Humulin® I 10ml vial; Kwikpen; 

Isulatard® 10ml vial; Innolet; 3ml Penfill

02.07.01 Isoprenaline 
02.06.01 Isosorbide Mononitrate 
13.06.02 Isotretinoin Roaccutane®

Rosccutane ®

13.06.01 Isotretinoin with erythromycin 

Isotrexin ® Isotretinoin 0.05% and erythromycin 2% gel

01.06.01 Ispaghula Husk 

Granules 3.5 g/sachet

02.06.03 Ivabradine 
13.05.03 Ixekizumab 

Taltz ®

13.10.02 Ketoconazole 
15.01.04.02 Ketorolac 
11.08.02 Ketorolac 0.5% eye drops 

Acular®

01.06.05 Klean-Prep® 

Oral powder, sugar-free sachets, Potassium chloride 742.5mg, Sodium chloride 1.465 g, Sodium bicarbonate 1.685 g, Sodium sulfate anhydrous 5.685 g, Polyethylene glycol 3350 59 g.

02.04 Labetalol 
04.08.01 Lacosamide  Vimpat ®
01.06.04 Lactulose 

Solution 3.1-3.7 g/5 ml

04.08.01 Lamotrigine 

Unlicensed use as a mood stabiliser

08.03.04.03 Lanreotide Somatuline® LA
01.03.05 Lansoprazole 

Capsules 15 mg, 30 mg

Orodispersible tablets 15 mg, 30 mg - For swallowing difficulties only

09.05.02.02 Lanthanum 

Fosrenol ®

11.06 Latanoprost 

eye drops; unit dose eye drops

11.06 Latanoprost with Timolol  

Xalacom®

10.01.03 Leflunomide 
13.05.03 Leflunomide 
02.08.01 Lepirudin 
02.06.02 Lercanidipine 
08.03.04.01 Letrozole 
06.07.02 Leuprorelin 
08.03.04.02 Leuprorelin Acetate Prostap® 3
04.08.01 Levetiracetam 

RED for Levetiracetam infusion

11.06 Levobunolol 

0.5% eye drops; unit dose eye drops

09.08.01 Levocarnitine Carnitor®
03.04.01 Levocetirizine Xyzal®
04.09.01 Levodopa 
11.03.01 Levofloxacin 0.5% eye drops 

Corneal ulcers

eye drops

single dose eye drops

04.02.01 Levomepromazine Nozinan®

existing patients

Black (RAG) rating for new patients

04.06 Levomepromazine 
07.03.05 Levonogrestrel 

Levonelle® 1500

06.02.01 Levothyroxine 
13.03 Lidocaine 

LMX 4® Lidocaone 40mg per 1 gram

Paediatric Use Only

11.07 Lidocaine 4% with Fluorescein 0.25% 

Minims®

04.07.03 Lidocaine 5% patches 
13.03 Lidocaine with Prilocaine 

Emla ® Lidocaine 25mg per 1 gram and Prilocaine 25mg per 1 gram

01.06.07 Linaclotide Constella®

Capsules 290 micrograms

06.01.02.03 Linagliptin 
13.10.05 LiquiBand® 
13.02.01 Liquid and White Soft Paraffin Ointment (50:50) 

Heavy Emollient

 Ointment

11.08.01 Liquid Paraffin eye ointment 

Lacri-lube®

06.01.02.03 Liraglutide 

Victoza®

Daily Dosing

04.04 Lisdexamfetamine 

AMBER 1 for ADHD in adults

RED for ADHD in children and young adults

Elvanse®

02.05.05.01 Lisinopril Zestril®
04.02.03 Lithium Carbonate 

Priadel®

04.02.03 Lithium Citrate 

Priadel® Liquid

11.04.02 Lodoxamide 0.1% eye drops 

Not for children under 4 years of age

Alomide®

04.03.01 Lofepramine 
01.04.02 Loperamide 

Tablets or capsules 2 mg

Syrup sugar-free 1 mg/5 ml

Contains sorbitol

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

03.04.01 Loratadine 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

04.01.02 Lorazepam 
04.01.02 Lorazepam 

anxiety

 

04.08.02 Lorazepam 
02.05.05.02 Losartan 
11.04.01 Loteprednol Lotemax®

Post-operative inflammation following occular surgeryin patients with steroid response.

0.5% eye drops

04.02.01 Lurasidone Latuda®

LCFT ONLY

13.06.02 Lymecycline 
01.01.01 Maalox Plus 

Palliative Care Use

Simeticone 5 mg per 1 ml, Magnesium hydroxide 39 mg per 1 ml, Aluminium hydroxide gel dried 44mg per 1 ml

Sugar-free

01.06.04 Macrogol oral powder 

Macrogol 13.8g sachets

Macrogol Paediatric 6.9g sachets

01.06.05 Macrogols Moviprep®

Oral powder, macrogol '3350'

01.06.05 Macrogols Plenvu®

Oral powder - macrogol 3550

For patients who have tried and failed with other PEG bowel cleansing preparations

09.05.01.03 Magnesium Aspartate 

Magnaspartate®

09.05.01.03 Magnesium Glycerophosphate 
09.05.01.03 Magnesium Sulphate 
01.01.01 Magnesium Trisilicate 

Suspension, 5% each of magnesium trisilicate, light magnesium carbonate and sodium bicarbonate in a suitable vehicle with a peppermnt flavour. Contains approximately 6 mmol sodium per 10 ml

13.10.04 Malathion 0.5% Derbac-M®

Derbac-M®

Scabies Treatment

02.02.05 Mannitol 
03.07 Mannitol inhalation Bronchitol ®

Inhalation powder capsules with device 40mg

Shared Care between Specialist Centre and Secondary Care

01.02 Mebeverine 

Tablets 135 mg

Modified release capsule 200 mg

Oral suspension 50 mg/5 ml sugar-free

06.04.01.02 Medroxyprogesterone Acetate Provera®
07.03.02.02 Medroxyprogesterone Acetate Depo-Provera®
08.03.02 Medroxyprogesterone Acetate Provera®
10.01.01 Mefenamic Acid 
08.03.02 Megestrol Acetate Megace®
04.11 Memantine 

Tablet, Orodispersible Tablet, Oral Solution

09.06.06 Menadiol Sodium Phosphate 
13.03 Menthol in Aqueous Cream 

1% and 2%

13.05.03 Mepacrine 

Unlicensed Medication

03.04.02 Mepolizumab Nucala®

Treatment of severe refractory eosinophilic asthma

 

09.08.01 Mercaptamine Cystagon®
01.05.03 Mercaptopurine 

Tablets 50 mg

Should only be used under expert supervision

01.05.01 Mesalazine 

Patients should be maintained on the same brand of mesalazine and only switched with advice from gastroenterology.

01.05.01 Mesalazine Asacol®

Suppositories 250 mg and 500mg

01.05.01 Mesalazine Pentasa®

Tablets m/r, e/c, 500mg, 1g

Granules, m/r, 1g/sachet, 4g/sachet

Retention enema 1g in 100ml

1 gram suppositories

01.05.01 Mesalazine Salofalk®

1 gram foam enema

2 gram foam enema

01.05.01 Mesalazine Octasa

Tablets m/r, e/c 400 mg, 800 mg, 1600mg

13.05.03 Mesalazine 
13.02.02 Metanium® 
02.07.02 Metaraminol 
06.01.02.02 Metformin 
04.10.03 Methadone 
01.05.03 Methotrexate 

Tablets 2.5 mg

Oral solution 10 mg in 5 ml (Rosemont)

Subcutaneous injection 50 mg/1 ml prefilled pen, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 17.5 mg, 20 mg, 22.5 mg, 25 mg, 27.5 mg, 30 mg (Licensed in Crohn's disease)

Should only be used under expert supervision

The dose is always a weekly dose.

10.01.03 Methotrexate 
13.05.03 Methotrexate 
13.05.02 Methoxypsoralen 

5-methoxypsoralen 20mg tablets

8-Methoxypsoralen 10mg tablets

8-Methoxypsoralen 0.005% gel

13.08.01 Methyl-5-Aminolevulinate 

Metvix ®

02.05.02 Methyldopa 
04.04 Methylphenidate 
04.04 Methylphenidate Hydrochloride MR 

Equasym®

Medikinet®

Concerta®

 

06.03.02 Methylprednisolone 
10.01.02.02 Methylprednisolone Acetate 

Depo-Medrone®

Depo-Medrone® with Lidocaine

04.06 Metoclopramide 
02.02.01 Metolazone 
13.10.01.02 Metronidazole  

0.75% gel - Anabact ® - only licensed for malodorous fungating tumors / malodourous gravitational and decubitus ulcers

0.75% cream / gel - Rosex ® - only licensed for Rosacea

06.07.03 Metyrapone Metopirone®
04.03.01 Mianserin 
12.03.02 Miconazole Daktarin®

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

13.10.02 Miconazole Daktarin®
04.08.02 Midazolam Buccolam®
02.07.02 Midodrine 
07.01.02 Mifepristone Mifegyne®
07.04.02 Mirabegron Betmiga®
04.03.04 Mirtazapine 
07.01.01 Misoprostol 200microgram tablets 
04.03.02 Moclobemide 
04.04 Modafinil Provigil®
13.04 Mometasone Furoate 0.1% 

Elocon® Cream / Ointment 30g / 100g

Potency : Potent

12.02.01 Mometasone Furoate nasal spray Nasonex®
03.03.02 Montelukast 

tablets

chewable tablets

sachets

04.07.02 Morphine 
12.03.04 Mouthwash solution tablets 

Hospital inpatients only

02.05.02 Moxonidine 
09.06.07 Multivitamin preparations Dalivit®

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

12.02.03 Mupirocin 2% Bactroban Nasal®
13.10.01.01 Mupirocin 2% 

Bactroban ® cream and ointment 15g

On microbiology advice

09.06.07 Mutivitamin 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

08.02.01 Mycophenolate Mofetil 
08.02.01 Mycophenolate Sodium Myfortic®
02.06.04 Naftidrofuryl 
01.06.06 Naloxegol 

Tablets 12.5 mg, 25 mg

04.10.03 Naltrexone Nalorex®
10.01.01 Naproxen 
08.02.04 Natalizumab Tysabri®

Treatment of rapidly evolving severe (RES) relapsing-remitting multiple sclerosis

02.04 Nebivolol Nebilet®
10.02.01 Neostigmine 
11.08.02 Nepafenac  

Nevanac®

02.06.03 Nicorandil 
13.06.01 Nicotinamide 

Nicam ® nicotinamide 4% gel

04.10 Nicotine Nicorette® Invisi patches
02.06.02 Nifedipine 
02.06.02 Nimodipine Nimotop®
07.03.03 Nonoxinol-9 20mg/1ml 

Gygel®

02.07.02 Noradrenaline / Norepinephrine 
06.04.01.02 Norethisterone 
13.05.03 Normal Immunoglobulin 
13.02.01 Nutraplus® 

Cream

Urea 10%

12.03.02 Nystatin oral suspension Nystan®
01.09.01 Obeticholic Acid Ocaliva

For use in line with NICE TA443 in treatment of Primary Biliary Cholangitis

08.02.04 Ocrelizumab Ocrevus®

Treatment of primary progressive multiple sclerosis.   

 

Treating relapsing-remitting multiple sclerosis. 

08.03.04.03 Octreotide Sandostatin®
06.04.01.01 Oestrogen only HRT patch 

Evorel® Estradot® Elelste Solo® MX

06.04.01.01 Oestrogen only HRT tablet 

Elleste-Solo® Premarin®

07.02.01 Oestrogens, Topical 

Estriol - Ovestin® intravaginal cream 0.01%

Estradiol - Vagifem® 10 microgram pessary

 

11.03.01 Ofloxacin 0.3% Eye drops 

Corneal ulcers

Exocin®

13.02.01 Oilatum® 

Cream

Medium Emollient

04.02.01 Olanzapine injection 

LCFT ONLY

 

04.02.01 Olanzapine tablets 

LCFT INITIATION ONLY

12.01.03 Olive Oil Ear Drops 

in a suitable container

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE in primary care.

03.01.01.01 Olodaterol 

ASTHMA:                                     COPD:

Not Licensed

Black                                     Green

Striverdi Respimat®

11.04.02 Olopatadine eye drops 

Not for children under 3 years of age

Opatanol®

03.04.02 Omalizumab Xolair®
01.03.05 Omeprazole 

Capsules 10 mg, 20 mg, 40 mg

Mups dispersible 10 mg- Paediatric only

 

01.03.05 Omeprazole IV 
04.06 Ondansetron 

NB off licence use as only licensed for post chemo/post operative use

06.01.06 Oral glucose tolerance test. 

75g Anhydrous glucose

07.03.02 Oral Progestogen-Only Contraceptives Norgeston®
07.03.02 Oral Progestogen-Only Contraceptives Micronor®
07.03.02 Oral Progestogen-Only Contraceptives Noriday®
09.02.01.02 Oral Rehydration Salts Dioralyte®

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

04.05.01 Orlistat 
04.08.01 Oxcarbazepine Trileptal®
11.07 Oxybuprocaine 

Minims® 0.4% unit dose eye drops

07.04.02 Oxybutynin 

Also transdermal patch

04.07.02 Oxycodone 
13.06.02 Oxytetracycline 
07.01.01 Oxytocin Syntocinon®

injection

04.02.01 Paliperidone Invega®

LCFT ONLY

04.02.02 Paliperidone palmitate  

LCFT ONLY

Xeplion®

05.03.05 Palivizumab Synagis®

Respiratory syncytial virus in infants

• To reduce the risk of respiratory syncytial virus (RSV) in infants with bronchopulmonary dysplasia (BPD) (also known as chronic lung disease) for the 18/19 season - Blueteq approval

• To reduce the risk of respiratory syncytial virus (RSV) in infants with congenital heart disease (CHD) for the 18/19 season - Blueteq approval

• to reduce the risk of respiratory syncytial virus (RSV) in infants with severe combined immunodeficiency syndrome (SCID) for the 18/19 season - Blueteq approval

01.09.04 Pancreatin 

Prescribe by brand name

Creon 10,000

Pancrex V capsules

Pancrease V powder

01.09.04 Pancreatin (Higher Strength) 

Prescribe by brand name

Creon 25,000

Creon 40.000

 

04.07.01 Paracetamol 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

09.06 Paravit CF ®

For Children with Cystic Fibrosis with pancreatic Insufficiency

Capsules

Solution - if unable to swallow capsules

04.03.03 Paroxetine 
03.01.05 Peak flow meter 
08.02.04 Peginterferon Alfa Pegasys®
08.02.04 Peginterferon Alfa ViraferonPeg®
08.02.04 Peginterferon Beta-1a Plegridy®
09.08.01 Penicillamine 
10.01.03 Penicillamine 
01.02 Peppermint Oil 

Capsule 0.2 ml

01.01.02 Peptac® 

Suspension, sugar-free, sodium bicarbonate 133.5 mg, sodium alginate 250 mg, calcium carbonate 80 mg per 5 ml. Contains 3.1 mmol Na+/5 ml

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

04.08.01 Perampanel Fycompa®
02.05.05.01 Perindopril erbumine or tert-butylamine 
13.10.04 Permethrin 5% Lyclear® Dermal Cream

Lyclear® Dermal Cream

Scabies Treatment

04.07.02 Pethidine 
04.03.02 Phenelzine 

Nardil®

04.08.01 Phenobarbital 
01.07.03 Phenol, Oily 

Injection 5% - 5 ml ampoule

02.05.04 Phenoxybenzamine Hydrochloride 
11.05 Phenylephrine Hydrochloride 

2.5% unit dose eye drops

10% unit dose eye drops

11.05 Phenylephrine Hydrochloride 5.4mg tropicamide 0.28mg 

Mydriasert®

04.08.01 Phenytoin 
04.08.02 Phenytoin 
03.09.01 Pholcodine Linctus, BP 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

09.05.02.01 Phosphate Polyfusor® 
09.05.02.01 Phosphate supplements 

Phosphate-Sandoz®

01.06.04 Phosphates (Rectal) Fleet® Ready to use Enema

Fleet Ready to use enema

09.06.06 Phytomenadione Konakion® MM

Konakion® MM Paediatric; oral, IM or IV injection

Konakion® MM; Slow IV injection or IV infusion

01.06.05 Picolax® 

Oral Powder, Sachets sugar-free, Sodium picosulfate 10mg, Magnesium Oxide 3.5 g, Citric acid anhydrous 12 g

11.06 Pilocarpine eye drops 

1% eye drops

2% eye drops; unit dose eye drops

12.03.05 pilocarpine Hydrochloride Salagen®
13.05.01 Pimecrolimus 

Elidel® 1% Cream 30g, 60g

06.01.02.03 Pioglitazone 
04.09.03 Piracetam Nootropil®
13.07 Podophyllotoxin 

Warticon ®

11.09 Polihexanide 0.02% eye drops 
09.02.01.01 Polystyrene Sulphonate Resins Calcium Resonium®
11.08.01 Polyvinyl Alcohol 1.4% 

Liquifilm Tears® Sno Tears®

03.05.02 Poractant Alfa 

Curosurf®

 

09.02.01.01 Potassium Chloride Sando-K®

Sando K®

Effervescent Tablets

09.02.01.01 Potassium Chloride 

Kay Cee L®

Syrup

07.04.03 Potassium Citrate 

Mixture

Also potassium citrate tablets (unlicensed) - named patient basis only - RED

13.11.06 Potassium Permanganate Permitabs®
11.03.01 Povidone iodine 5% 

Unit Dose Eye drops

13.11.04 Povidone-Iodine 

Videne ® Alcoholic Solution 10%

              Antiseptic Solution 10%

              Surgical Scrub 7.5%

04.09.01 Pramipexole 
04.09.04 Pramipexole 
02.09 Prasugrel Efient®
01.05.02 Prednisolone 

Tablets 1 mg, 2.5 mg, 5 mg

Retention enema 20 mg in 100 ml

Suppositories 5 mg

06.03.02 Prednisolone 
08.02.02 Prednisolone 
11.04.01 Prednisolone eye drops 

0.1% Eye drops

11.04.01 Prednisolone eye drops 

0.5% eye drops; unit dose eye drops

1% eye drops Pred Forte®

04.07.03 Pregabalin 
04.08.01 Pregabalin 
04.09.04 Pregabalin 
04.08.01 Primidone 
04.06 Prochlorperazine 
04.09.02 Procyclidine 
04.02.01 Promazine Hydrochloride Promazine®
03.04.01 Promethazine Phenergan®
02.03.02 Propafenone 
11.09 Propamidine Isetionate 0.1% eye drops 

Brolene®

02.04 Propranolol 
06.02.02 Propylthiouracil 
02.08.03 Protamine Sulphate 
06.05.01 Protirelin TRH
11.07 Proxymetacaine 0.5% 

Minims®

01.06.07 Prucalopride Resolor®

Tablets 1 mg, 2 mg

10.02.01 Pyridostigmine Bromide 

Mestinon®

09.06.02 Pyridoxine Hydrochloride 

5mg/5ml suspension

10mg tablets

04.02.01 Quetiapine 

LCFT INITIATION ONLY

tablets and XL tablets

06.07.01 Quinagolide Norprolac®
10.02.02 Quinine 
06.04.01.01 Raloxifene  

Primary prevention of osteoporotic fragility fractures in postmenopausal women: 

Black

Secondary prevention of osteoporotic fragility fractures in postmenopausal women: 

Green

02.05.05.01 Ramipril 
11.08.02 Ranibizumab 10mg/1ml 

Lucentis®

01.03.01 Ranitidine 

Tablets 150 mg, 300 mg

Effervescent tablets 150 mg

Oral solution 75 mg/5 ml (75 mg/ 5ml is a licensed standard strength used in paediatrics (either Zantac or Rosemont product which contain 8% alcohol)

Injection 25 mg/1 ml

13.03 Ranitidine 

Unlicensed Indication

Dermatology Initiation only

02.06.03 Ranolazine Ranexa®
04.09.01 Rasagiline 

BLACK unlicensed MS

10.01.04 Rasburicase 

Fasturtec®

04.03.04 Reboxetine 

Edronex®

03.04.02 Reslizumab Cinqaero®

Treating severe eosinophilic asthma in adults (NICE TA479)

04.08.01 Retigabine 
11.08.01 Retinol palmitate eye ointment 

Hylo Night®

04.09.03 Riluzole Rilutek®
06.06.02 Risedronate  
06.06.02 Risedronate 
04.02.01 Risperidone 

LCFT INITIATION ONLY

04.02.02 Risperidone 

LCFT ONLY

Risperdal Consta®

08.02.03 Rituximab MabThera®
02.08.02 Rivaroxaban Xarelto®
04.11 Rivastigmine 

Capsule, Oral Solution, Transdermal Patch

04.07.04.01 Rizatriptan Maxalt®
03.03.03 Roflumilast Daxas®
04.09.01 Ropinirole 
04.09.04 Ropinirole 
02.12 Rosuvastatin 
04.09.01 Rotigotine 
04.09.04 Rotigotine 
04.08.01 Rufinamide Inovelon®
02.05.05.02 Sacubitril valsartan Entresto®

Restricted Item Must be stabilised by secondary care before transfer to primary care. Initiated by consultant cardiologist

03.01.01.01 Salbutamol 

Asthma:                                                                   COPD:

• First line SABA                                                      • First line SABA


 • Inhaler, or Easyhaler, Easi-breathe

• Nebulised 

• Inhalation route preferred over oral route

07.01.03 Salbutamol 

injection

12.03.05 Salivix® pastilles 
03.01.01.01 Salmeterol 

Asthma:                                              COPD:

MDI; Accuhaler

01.07.02 Scheriproct®  

Ointment 30 g, suppositories 12

13.05.03 Secukinumab 

Cosentyx®

04.09.01 Selegiline Hydrochloride 
13.09 Selsun® 

Selenium Sulphide 25mg per 1ml

 for chronic conditions

06.01.02.03 Semaglutide Ozempic®
01.06.02 Senna 

Tablets 7.5 mg

Syrup sugar-free, 7.5 mg/5 ml

04.03.03 Sertraline 
09.05.02.02 Sevelamer Carbonate 

Renvela®

09.05.02.02 Sevelamer Hydrochloride  

Renagel®

07.04.05 Sildenafil 
13.10.01.01 Silver Sulfadiazine 

Flamazine ® 1% cream

01.01.01 Simeticone infacol®

Oral suspension 40mg per 1 ml

Red unlicensed use in Endoscopy

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

03.09.02 Simple Linctus, BP 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

02.12 Simvastatin 
08.02.02 Sirolimus Rapamune®
09.08.01 Sodium Benzoate  
09.02.01.03 Sodium Bicarbonate 
12.01.03 Sodium Bicarbonate 

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE in primary care.

11.08.01 Sodium Chloride 
13.11.01 Sodium Chloride Normasol®
03.07 Sodium chloride (hypertonic) 

3%, 6%, 7%  nebuliser solution

03.01.05 Sodium chloride 0.9% 
07.04.04 Sodium chloride 0.9% 

50ml urotainer

100ml bladder irrigation

11.08.01 Sodium Chloride 0.9% 

Minims - preservative free

07.04.04 Sodium chloride 0.9% in 3L irrigation 
12.02.02 Sodium chloride 0.9% nasal drops 

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE in primary care.

12.02.02 Sodium chloride 0.9% nasal spray 

For Post-operative use ONLY

Supply from Inpatient pharmacy only

11.99.99.99 Sodium Chloride 5% eye drops 

Regular ophthalmology review required

01.06.04 Sodium Citrate 

Micro-enema

Acute constipation

11.04.02 Sodium Cromoglicate 2% eye drops 

Allergic conjuctivitis - prophylaxis

Included in the CCG Low Priority for Prescribing Policy

09.01.01.01 Sodium Feredetate 

Paediatrics only

Sytron®

 

11.99.99.99 Sodium Hyaluronate  

Amvisc® 1.2% & 1.6% syringe

11.08.01 Sodium Hyaluronate 0.1% 

Hylo-Tear®

11.08.01 Sodium Hyaluronate 0.1%, Carmellose 0.5% glycerol 0.9% eye drops 

Optive Fusion®

11.08.01 Sodium Hyaluronate 0.2% 

Hylo-Forte®

09.08.01 Sodium Phenylbutyrate Ammonaps®
01.06.02 Sodium Picosulfate 1mg/1ml Oral SF solution 
02.13 Sodium Tetradecyl Sulphate Fibro-Vein®
04.02.03 Sodium valproate 
04.08.01 Sodium Valproate Epilim®Epilim Chrono®
10.01.03 Soldium Aurothomalate 

Myocrisin®

07.04.02 Solifenacin 
06.05.01 Somatropin Saizen®
02.04 Sotalol 
03.01.05 Space Chamber 

Masks available separately: Small, Medium and Large

02.02.03 Spironolactone 
02.10.02 Streptokinase 
01.03.03 Sucralfate 

Consultant Initiation

Tablets 1 g

Suspension 1 g/5 ml

10.01.03 Sulfasalazine 
04.07.04.01 Sumatriptan 

tablets/injection

13.08.01 Sunsense® Ultra 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

13.05.02 Tacalcitol Curatoderm®

Curatoderm ® Ointement 30g / 100g

08.02.02 Tacrolimus 
13.05.01 Tacrolimus 

Protopic® 0.03% Ointmnet 30g, 60g

               0.1% ointment 30g, 60g

07.04.05 Tadalafil Cialis®
11.06 Tafluprost (Preservative Free) 15micrograms/ml 

Saflutan®

08.03.04.01 Tamoxifen 
07.04.01 Tamsulosin Hydrochloride 
13.05.02 Tazarotene 

Zorac ® gel 0.05% 30g

                 0.1% 30g

04.01.01 Temazepam 
02.10.02 Tenecteplase Metalyse®
13.10.02 Terbinafine 1% cream 
03.01.01.01 Terbutaline 

Asthma:                                          COPD:

Turbohaler; Nebuliser

NB tablets and oral solution are non-formulary

08.02.04 Teriflunomide Aubagio®
06.06.01 Teriparatide Forsteo®

Recommendation is for women ONLY

(RAG Status is Black for men)

06.05.02 Terlipressin 
06.04.02 Testosterone and Esters Sustanon 100®
06.04.02 Testosterone gel  

Tostran ®

Testogel ®

BLACK (rag) rating for femaile sexual dysfunction following oophorectomy or ovarian failure. LMMG Review

06.04.02 Testosterone oral Restandol Testocaps®
06.04.02 Testosterone undecanoate Nebido®
04.09.03 Tetrabenazine Xenazine® 25
13.03 Tetracaine 

Ametop® 40mg per 1 gram

06.05.01 Tetracosactide Synacthen®
08.02.04 Thalidomide Celgene®
13.05.03 Thalidomide 

Unlicnesed Indication

03.01.03 Theophylline 
04.10 Thiamine 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

09.06.02 Thiamine 
09.06.02 Thiamine 

Pabrinex®

06.04.01.01 Tibolone 

Livial®

02.09 Ticagrelor Brilique®
11.06 Timolol eye drops 

0.1% unit dose eye drops

0.25% eye drops, long acting eye drops; unit dose eye drops

0.5% eye drops, long acting eye drops; unit dose eye drops

02.08.01 Tinzaparin 
13.10.02 Tioconazole Trosyl®
03.01.02 Tiotropium 

Asthma:                                      COPD:  

Amber                                                                        

Specialist initiation

Only Respimat® device is licensed for asthma

Spiriva® Hard capsules 18micrograms with HandiHaler® 
Spiriva® Respimat® 2.5micrograms/inhalation

Braltus® 10microgram inhalation powder capsules with Zonda® inhaler

5micrograms (2puffs) via the Respimat® is equivalent to 18micrograms via the HandiHaler®

Braltus® and Spiriva® Handihaler and Respimat are clinically equivalent and produce the same amount of active ingredient in the body. 10 micrograms of Braltus® is equivalent to 18 micrograms of Spiriva® Handihaler and 5 micrograms of Respimat.

03.01.04 Tiotropium & olodaterol 

Asthma:                                                   COPD:

Black                                                  Green

Not licensed                                                  

Spiolto Respimat ®

02.09 Tirofiban Aggrastat®
10.02.02 Tizanidine 
10.01.03 Tocilizumab 

RoActemra®

01.05.03 Tofactinib 

Xeljanz® 5mg and 10mg tablets

To be used in line with NICE TA547 for moderately to severely active ulcerative colitis

07.04.02 Tolterodine 
06.05.02 Tolvaptan Samsca®
04.07.04.02 Topiramate 

migraine prophylaxis

04.08.01 Topiramate 
02.11 Tranexamic Acid 

Oral

02.11 Tranexamic Acid  Injection
11.06 Travoprost 

Travatan®

40microgram/ml eye drops

11.06 Travoprost with Timolol 

DuoTrav®

04.03.01 Trazodone 
13.06.01 Tretinoin with clindamycin 

Treclin® tretinoin 250microgram per 1g and clindamycin 10mg per 1g gel

10.01.02.02 Triamcinolone Acetonide 

Adcortyl®

Kenalog®

04.02.01 Trifluoperazine 
04.09.02 Trihexyphenidyl 
13.06.02 Trimethoprim dermatology

Consultant Initiation Only

06.07.02 Triptorelin 

Decapeptyl® SR (Precocious Puberty)

11.05 Tropicamide eye drops 

0.5% unit dose eye drops

1% eye drops; unit dose eye drops

07.04.02 Trospium Regurin® XL
09.08.01 Ubidecarenone  
06.07.02 Ulipristal Esmya®

Esyma®

See MHRA Safety Alert: Ulipristal

See LMMG Prescribing Guidance: Ulipristal

07.03.05 Ulipristal 

EllaOne®

Primary care

Secondary care - only approved for the safe centre RPH

03.01.02 Umeclidinium 

Asthma:                                   COPD:

Not Licensed

Black                                 Green

Incruse Ellipta®

03.01.04 Umeclidinium & vilanterol 

Asthma:                                                 COPD:

Black                                                Green

Not llicensed

Anoro Ellipta ®

 

13.02.01 Unguentum M® 

Cream

Medium Emolllient

02.10.02 Urokinase 
01.09.01 Ursodeoxycholic acid 

Tablets 150 mg

Capsules 250 mg

Suspension 250 mg in 5 ml

Consultant initiation

01.05.03 Ustekinumab Stelara

For use in line with NICE TA456 for moderately to severely active Chron's Disease after previous treatment

01.05.03 Ustekinumab 

Stelara For use in line with NICE TA 456 for previously treated moderately to severely active Crohn’s disease in adults.

10.01.03 Ustekinumab 

Stelara®

13.05.03 Ustekinumab 
13.08.01 Uvistat® 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

04.02.03 Valproic Acid 

Depakote®

06.05.02 Vasopressin 
01.05.03 Vedolizumab 

Concentrate for intravenous infusion, powder for reconstitution 300 mg vials

Should only be used under expert supervision

04.03.04 Venlafaxine 
02.06.02 Verapamil 
11.08.02 Verteporfin 15mg powder for solution 

Visudyne®

04.08.01 Vigabatrin Sabril®
13.05.01 Viscopaste 
A5.08.09 Viscopaste 
09.06.07 Vitamin and mineral supplements Forceval®

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

04.10 Vitamin B substances with ascorbic acid Pabrinex®
09.06.01 Vitamins A and D 

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

03.01.05 Volumatic® 

Paediatric Use only 

Adults - use Space Chamber

04.03.03 Vortioxetine 
02.08.02 Warfarin 
12.02.02 Xylometazoline Otrivine®

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE IN primary care.

09.05.04 Zinc Sulphate Solvazinc®
06.06.02 Zoledronic Acid 
04.07.04.01 Zolmitriptan 
04.01.01 Zolpidem 
04.08.01 Zonisamide Zonegran®
04.01.01 Zopiclone 
04.02.01 Zuclopenthixol 
04.02.01 Zuclopenthixol Acetate 

LCFT ONLY

Clopixol Acuphase®

 

04.02.02 Zuclopenthixol Decanoate 

LCFT INITIATION  ONLY

Central Lancashire Formulary